All lobbying filings
NOVAVAX, INC
NOVAVAX, INC filed a Q4 report for NOVAVAX, INC on January 20, 2026.
Lobbying for NOVAVAX, INC
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$110,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Maryland
Government bodies contacted
2
Lobbying activity
1
Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks